Skip to main content
Erschienen in: Acta Neurologica Belgica 2/2019

10.11.2018 | Original Article

Mental health in Parkinson’s disease after receiving aquatic therapy: a clinical trial

verfasst von: Sagrario Pérez-de la Cruz

Erschienen in: Acta Neurologica Belgica | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Depression is a major determinant of quality of life in individuals with Parkinson’s disease. The aim of this study was to evaluate the effects of a program of Ai Chi aquatic therapy on pain, depression and quality of life in people with Parkinson’s disease. Participants were randomized to receive dry land physiotherapy treatment (control group) or aquatic Ai Chi sessions in the pool (experimental group). The outcome measures used included the VAS pain scale, the Geriatric Depression Scale and the SF-36 quality of life scale. In the experimental group treated with aquatic therapy, significant differences were found in the pain, depression and quality of life variables post-treatment (p < 0.001). In the control group, improvements were only observed in the VAS pain scale, and these were less significant than the changes found in the experimental group (p = 0.006). The significant changes registered in the experimental group at the post-treatment assessment were maintained 1 month after completing the experimental intervention program. In conclusion, these findings indicate that physical exercise performed in water has positive effects on some of the factors that influence mood and quality of life in people with Parkinson’s disease.
Literatur
1.
Zurück zum Zitat Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF (2016) Prevalence of anxiety in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 31(8):1125–1133CrossRefPubMed Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF (2016) Prevalence of anxiety in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 31(8):1125–1133CrossRefPubMed
2.
Zurück zum Zitat Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245CrossRefPubMed Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245CrossRefPubMed
3.
Zurück zum Zitat Dissanayaka NN, Sellbach A, Matheson S, O’Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD (2010) Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov Disord 25(7):838–845CrossRefPubMed Dissanayaka NN, Sellbach A, Matheson S, O’Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD (2010) Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov Disord 25(7):838–845CrossRefPubMed
4.
Zurück zum Zitat Dissanayaka NN, Sellbach A, Silburn PA, O’Sullivan JD, Marsh R, Mellick GD (2011) Factors associated with depression in Parkinson’s disease. J Affect Disord 132(1–2):82–88CrossRefPubMed Dissanayaka NN, Sellbach A, Silburn PA, O’Sullivan JD, Marsh R, Mellick GD (2011) Factors associated with depression in Parkinson’s disease. J Affect Disord 132(1–2):82–88CrossRefPubMed
5.
Zurück zum Zitat Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23(2):183–189CrossRefPubMed Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23(2):183–189CrossRefPubMed
6.
Zurück zum Zitat Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 8(3):193–197CrossRefPubMed Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 8(3):193–197CrossRefPubMed
7.
Zurück zum Zitat Ferreri F, Agbokou C, Gauthier S (2006) Recognition and management of neuropsychiatric complications in Parkinson’s disease. CMAJ 175(12):1545–1552CrossRefPubMedPubMedCentral Ferreri F, Agbokou C, Gauthier S (2006) Recognition and management of neuropsychiatric complications in Parkinson’s disease. CMAJ 175(12):1545–1552CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Köhler S (2013) Modeling depression in Parkinson disease diseasespecific and nonspecific risk factors. Neurology 17(12):1036–1043CrossRef Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Köhler S (2013) Modeling depression in Parkinson disease diseasespecific and nonspecific risk factors. Neurology 17(12):1036–1043CrossRef
11.
Zurück zum Zitat Chana-Cuevas P, Juri-Claverías C, Alburquerque D, Soto-Olmedo MJ, Benavides-Canales O (2006) Risk factors associated to the presentation of episodes of major depression in a population of outpatients with Parkinson’s disease. Rev Neurol 42(9):521–524PubMed Chana-Cuevas P, Juri-Claverías C, Alburquerque D, Soto-Olmedo MJ, Benavides-Canales O (2006) Risk factors associated to the presentation of episodes of major depression in a population of outpatients with Parkinson’s disease. Rev Neurol 42(9):521–524PubMed
12.
Zurück zum Zitat Bosboom JL, Stoffers D, Wolters E (2004) Cognitive dysfunction and dementia in Parkinson’s disease. J Neural Transm 111(10–11):1303–1315CrossRefPubMed Bosboom JL, Stoffers D, Wolters E (2004) Cognitive dysfunction and dementia in Parkinson’s disease. J Neural Transm 111(10–11):1303–1315CrossRefPubMed
13.
Zurück zum Zitat Schrag A (2006) Quality of life and depression in Parkinson’s disease. J Neurol Sci 248(1–2):151–157CrossRefPubMed Schrag A (2006) Quality of life and depression in Parkinson’s disease. J Neurol Sci 248(1–2):151–157CrossRefPubMed
14.
Zurück zum Zitat Poewe W, Seppi K (2001) Treatment options for depression and psychosis in Parkinson’s disease. J Neurol 248(3):12–21CrossRef Poewe W, Seppi K (2001) Treatment options for depression and psychosis in Parkinson’s disease. J Neurol 248(3):12–21CrossRef
15.
Zurück zum Zitat Ford B (2009) Parkinson disease: pain in Parkinson disease: the hidden epidemic. Nat Rev Neurol 5(5):242–243CrossRefPubMed Ford B (2009) Parkinson disease: pain in Parkinson disease: the hidden epidemic. Nat Rev Neurol 5(5):242–243CrossRefPubMed
16.
Zurück zum Zitat Santos H, García-Antelo MJ, Ivánovic-Barbeito Y, Díaz-Silva JJ, Sobrido MJ (2012) Tratamiento de los trastornos de la marcha en la enfermedad de Parkinson. Rev Neurol 54(5):61–68 Santos H, García-Antelo MJ, Ivánovic-Barbeito Y, Díaz-Silva JJ, Sobrido MJ (2012) Tratamiento de los trastornos de la marcha en la enfermedad de Parkinson. Rev Neurol 54(5):61–68
17.
Zurück zum Zitat Ayán C, Cancela JM (2012) Effects of aquatic exercise on persons with Parkinson’s disease: a preliminary study. Sci Sports 27:300–304CrossRef Ayán C, Cancela JM (2012) Effects of aquatic exercise on persons with Parkinson’s disease: a preliminary study. Sci Sports 27:300–304CrossRef
18.
Zurück zum Zitat Moreno CB, Hernández-Beltrán N, Munévar D, Gutiérrez-Álvarez AM (2002) Dolor neuropático central en enfermedad de Parkinson. Neurologia 27(8):500–503CrossRef Moreno CB, Hernández-Beltrán N, Munévar D, Gutiérrez-Álvarez AM (2002) Dolor neuropático central en enfermedad de Parkinson. Neurologia 27(8):500–503CrossRef
19.
Zurück zum Zitat Pérez-de la Cruz S, García-Luengo AV, Lambeck J (2016) Effects of an Ai Chi fall prevention programme for patients with Parkinson’s disease. Neurologia 31(3):176–182CrossRefPubMed Pérez-de la Cruz S, García-Luengo AV, Lambeck J (2016) Effects of an Ai Chi fall prevention programme for patients with Parkinson’s disease. Neurologia 31(3):176–182CrossRefPubMed
20.
Zurück zum Zitat Hoehn MM, Yahr MD (1998) Parkinsonism: onset, progression, and mortality. Neurology 50(2):318–334CrossRefPubMed Hoehn MM, Yahr MD (1998) Parkinsonism: onset, progression, and mortality. Neurology 50(2):318–334CrossRefPubMed
21.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
22.
Zurück zum Zitat Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J (2005) El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit 19(2):135–150CrossRefPubMed Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J (2005) El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit 19(2):135–150CrossRefPubMed
23.
Zurück zum Zitat Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49CrossRef Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49CrossRef
24.
Zurück zum Zitat Martínez de la Iglesia J, Onís Vilches MC, Dueñas Herrero R, Albert Colomer C, Aguado Taberné C, Luque Luque R (2002) Versión española del Cuestionario de Yesavage abreviado (GDS) para el despistaje de depresión en mayores de 65 años: adaptación y validación. MEDIFAM 12:620–630 Martínez de la Iglesia J, Onís Vilches MC, Dueñas Herrero R, Albert Colomer C, Aguado Taberné C, Luque Luque R (2002) Versión española del Cuestionario de Yesavage abreviado (GDS) para el despistaje de depresión en mayores de 65 años: adaptación y validación. MEDIFAM 12:620–630
25.
Zurück zum Zitat Varas-Fabra F, Castro E, Pérula LA, Fernández MJ, Ruiz R, Enciso I (2006) Caídas de ancianos de la comunidad: prevalencia, consecuencias y factores asociados. Aten Primaria 38(8):450–455CrossRefPubMed Varas-Fabra F, Castro E, Pérula LA, Fernández MJ, Ruiz R, Enciso I (2006) Caídas de ancianos de la comunidad: prevalencia, consecuencias y factores asociados. Aten Primaria 38(8):450–455CrossRefPubMed
26.
Zurück zum Zitat Stubbs B, Binnekade T, Eggermont L, Sepehry AA, Patchay S (2004) Pain and the risk for falls in community-dwelling older adults: systematic review and meta-analysis. Arch Phys Med Rehabil 95(1):175–187CrossRef Stubbs B, Binnekade T, Eggermont L, Sepehry AA, Patchay S (2004) Pain and the risk for falls in community-dwelling older adults: systematic review and meta-analysis. Arch Phys Med Rehabil 95(1):175–187CrossRef
27.
Zurück zum Zitat Gómez-Esteban JC, Tijero B, Somme J, Ciordia R, Berganzo K, Rouco I (2011) Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease. J Neurol 258:494–499CrossRefPubMed Gómez-Esteban JC, Tijero B, Somme J, Ciordia R, Berganzo K, Rouco I (2011) Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease. J Neurol 258:494–499CrossRefPubMed
28.
Zurück zum Zitat Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, NMSS Validation Group (2011) The impact of non motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 26:399–406CrossRefPubMed Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, NMSS Validation Group (2011) The impact of non motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 26:399–406CrossRefPubMed
29.
Zurück zum Zitat Opara JA, Brola W, Leonardi M, Błaszczyk B (2012) Quality of life in Parkinson’s disease. J Med Life 5:375–381PubMedPubMedCentral Opara JA, Brola W, Leonardi M, Błaszczyk B (2012) Quality of life in Parkinson’s disease. J Med Life 5:375–381PubMedPubMedCentral
30.
Zurück zum Zitat Huang TT, Liu CB, Tsai YH, Chin YF, Wong CH (2015) Physical fitness exercise versus cognitive behavior therapy on reducing the depressive symptoms among community-dwelling elderly adults: a randomized controlled trial. Int J Nurs Stud 2015(52):1542–1552CrossRef Huang TT, Liu CB, Tsai YH, Chin YF, Wong CH (2015) Physical fitness exercise versus cognitive behavior therapy on reducing the depressive symptoms among community-dwelling elderly adults: a randomized controlled trial. Int J Nurs Stud 2015(52):1542–1552CrossRef
31.
Zurück zum Zitat Leentjens AFG, Lousberg R, Verhey FJR (2002) Markers for depression in Parkinson’s disease. Acta Pyschatr Scand 106(3):196–201CrossRef Leentjens AFG, Lousberg R, Verhey FJR (2002) Markers for depression in Parkinson’s disease. Acta Pyschatr Scand 106(3):196–201CrossRef
32.
Zurück zum Zitat Havlikova E, Rosenberger J, Nagyova I, Middel B, Dubayova T, Gdovinova Z (2008) Impact of fatigue on quality of life in patients with Parkinson’s disease. Eur J Neurol 15(5):475–480CrossRefPubMed Havlikova E, Rosenberger J, Nagyova I, Middel B, Dubayova T, Gdovinova Z (2008) Impact of fatigue on quality of life in patients with Parkinson’s disease. Eur J Neurol 15(5):475–480CrossRefPubMed
33.
Zurück zum Zitat Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1134CrossRefPubMed Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1134CrossRefPubMed
34.
Zurück zum Zitat Behari A, Srivastava AK, Pandey RM (2005) Quality of life in patients with Parkinson’s disease. Parkinsonism Relat Disord 11:221–226CrossRefPubMed Behari A, Srivastava AK, Pandey RM (2005) Quality of life in patients with Parkinson’s disease. Parkinsonism Relat Disord 11:221–226CrossRefPubMed
35.
Zurück zum Zitat Hinnell C, Hurt CS, Landau S, Brown RG, Samuel M, Grp P-PS (2012) Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson’s disease? Mov Disord 27:236–241CrossRefPubMed Hinnell C, Hurt CS, Landau S, Brown RG, Samuel M, Grp P-PS (2012) Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson’s disease? Mov Disord 27:236–241CrossRefPubMed
Metadaten
Titel
Mental health in Parkinson’s disease after receiving aquatic therapy: a clinical trial
verfasst von
Sagrario Pérez-de la Cruz
Publikationsdatum
10.11.2018
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 2/2019
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-018-1034-5

Weitere Artikel der Ausgabe 2/2019

Acta Neurologica Belgica 2/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.